[1]向文采,黄修仿,叶 超,等.老年胃肠道间质瘤肝转移患者术前血清ALT与AST比值与预后的相关性研究[J].现代检验医学杂志,2022,37(02):190-194.[doi:10.3969/j.issn.1671-7414.2022.02.038]
 XIANG Wen-cai,HUANG Xiu-fang,YE Chao,et al.Correlation between Preoperative Serum Alanine Aminotransferase to Aspartate Aminotransferase Ratio and Prognosis in Elderly Patients with Liver Metastasis from Gastrointestinal Stromal Tumor[J].Journal of Modern Laboratory Medicine,2022,37(02):190-194.[doi:10.3969/j.issn.1671-7414.2022.02.038]
点击复制

老年胃肠道间质瘤肝转移患者术前血清ALT与AST比值与预后的相关性研究()
分享到:

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年02期
页码:
190-194
栏目:
检验与临床
出版日期:
2022-03-15

文章信息/Info

Title:
Correlation between Preoperative Serum Alanine Aminotransferase to Aspartate Aminotransferase Ratio and Prognosis in Elderly Patients with Liver Metastasis from Gastrointestinal Stromal Tumor
文章编号:
1671-7414(2022)02-190-06
作者:
向文采 黄修仿叶 超刘 俊
(汉川市人民医院普外科, 湖北汉川 431600)
Author(s):
XIANG Wen-cai HUANG Xiu-fang YE Chao LIU Jun
(Department of General Surgery, Hanchuan People’s Hospital, Hubei Hanchuan 431600, China)
关键词:
丙氨酸氨基转移酶天门冬氨酸氨基转移酶老年胃肠道间质瘤肝转移
分类号:
R735;R730.43
DOI:
10.3969/j.issn.1671-7414.2022.02.038
文献标志码:
A
摘要:
目的 探讨术前血清丙氨酸氨基转移酶(alanine aminotransferase, ALT)与天门冬氨酸氨基转移酶(aspartate aminotransferase, AST)比值(LSR) 对老年胃肠道间质瘤(gastrointestinal stromal tumor, GIST) 肝转移患者预后的影响。方法 选取2010 年1 月~ 2016 年5 月在湖北省汉川市人民医院治疗的189 例老年GIST 肝转移患者的临床资料进行回顾性分析。分析其临床病理特征及与生存预后的关系。根据ROC 曲线得到LSR 最佳截点为1.39,根据此截点将患者分为LSR<1.39 组(n=132) 和LSR ≥ 1.39 组(n=57),比较各组患者的生存率,用Kaplan-Meier 法进行生存分析,并进行COX单因素和多因素分析。结果 所有患者随访期为8~68 个月,中位数21.3 个月。所有患者1 年、3 年和5 年生存率(OS)分别为89.95%,71.43% 和50.26%。LSR<1.39 组1 年、3 年和5 年OS 分别为93.18%,77.27% 和56.82%,LSR ≥ 1.39组1 年,3 年和5 年OS 分别为82.46%,57.89% 和35.09%。两组间1 年、3 年和5 年OS 差异均有统计学意义(χ2=5.065,7.325,7.520,均P <0.05)。LSR<1.39 组与LSR ≥ 1.39 组患者的肿瘤大小、核分裂数、淋巴结转移及NIH 危险度分级差异均有统计学意义(χ2=5.011~15.452,均P <0.05),性别及肿瘤位置差异无统计学意义(χ2=0.268, 0.611, 均P>0.05)。COX 单因素分析结果显示,肿瘤位置(OR=1.514,95% CI:1.081~2.121,P=0.016),肿瘤大小(OR=2.201,95% CI:1.373~3.530,P=0.001),核分裂数(OR=1.505,95% CI:1.117~2.028,P=0.007),淋巴结转移(OR=1.744,95% CI:1.338~2.272,P=0.000),NIH 危险度分级(OR=2.678,95% CI:2.146~3.342,P=0.000) 和LSR(OR=2.344,95% CI:1.839~2.989,P=0.000) 是老年GIST 肝转移患者预后的影响因素;COX 多因素分析结果显示,肿瘤大小(OR=1.610,95% CI:1.209~2.143,P=0.001),淋巴结转移(OR=1.564,95% CI:1.181~2.069,P=0.002),NIH 危险度分级(OR=2.565,95% CI:2.072~3.176,P=0.000) 和LSR(OR=2.206,95% CI:1720~2.829,P=0.000) 是老年GIST 肝转移患者预后的独立影响因素(P<0.05)。结论 术前LSR 是老年GIST 肝转移患者预后的独立危险因素。
Abstract:
Objective To investigate the effect of preoperative serum alanine aminotransferase(ALT) and aspartate aminotransferase(AST) ratio (LSR) on liver metastasis prognosis in elderly gastrointestinal stroma (GIST) patients. Methods  The clinical data of 189 elderly patients with GIST liver metastasis treated from January 2010 to May 2016 in Hanchuan City People’s Hospital of Hubei Province were selected for retrospective analysis. Clinicopathological characteristics and their relationship with survival prognosis were analyzed. The best LSR from ROC curve was 1.39, which divided patients into LSR <1.39 (n=132) and LSR ≥ 1.39 (n=57). Survival rate was compared in each groups. Survival analysis was performed by Kaplan- Meier and COX single and multifactor analysis. Results All patient follow-up period was 8~68 months, with a median of 21.3 months. All patients were 1-year OS 89.95% (170/189), 3-year OS 71.43% (135/189), and 5-year OS 50.26% (95/189). In LSR<1.39 group 1-year, 3-year and 5-year OS were 93.18%, 77.27% and 56.82% respectively. In LSR ≥ 1.39 group 1-year, 3-year and 5-year OS were 82.46%, 57.89% and 35.09%, respectively. The 1-year, 3-year and 5-year OS differences between the two groups had statistical significance(t=5.065, 7.325, 7.520, all P<0.05). Tumor size, nuclear division, lymph node metastasis, and NIH risk classification had statistical significance in LSR<1.39 and LSR ≥ 1.39 (χ2=5.011 ~15.452, all P<0.05), gender and tumor location differences had no statistical significance (χ2=0.268, 0.611, all P>0.05). The results of COX singlefactor analysis showed that tumor location(OR=1.514,95%CI:1.081~2.121,P=0.016), tumor size(OR=2.201,95%CI: 1.373~3.530,P=0.001), nuclear division number(OR=1.505,95%CI:1.117~2.028,P=0.007), lymph node metastasis(OR=1.744, 95%CI:1.338~2.272, P=0.000), NIH risk classification(OR=2.678, 95%CI:2.146~3.342, P=0.000) and LSR(OR=2.344, 95%CI:1.839~2.989, P=0.000) were the influencing factors affecting the prognosis of elderly patients with GIST liver metastasis (all P<0.05). The results of COX multi-factor analysis showed that tumor size(OR=1.610, 95%CI:1.209~2.143, P=0.001), lymph node metastasis (OR=1.564, 95%CI:1.181~2.069, P=0.002), NIH risk classification (OR=2.565, 95%CI: 2.072~3.176, P=0.000) and LSR(OR=2.206, 95%CI:1720~2.829, P=0.000) were the independent influencing factors for the prognosis in elderly patients with GIST liver metastasis (all P<0.05). Conclusion LSR is an independent risk factor for elderly patients with GIST liver metastasis, and suggests that their liver function should be improved to improve their prognosis and prolong survival.

参考文献/References:

[1] CHEN Yongpeng, HUANG Liwen, LIN Xiaoyu, et al. Alanine aminotransferase influencing performances of routine available tests detecting hepatitis B-related cirrhosis[J]. Journal of Viral Hepatitis, 2020, 27(8): 826-836.
[2] CHOI S H, KIM B T, SHIN J, et al. Combined effect of serum alanine aminotransferase and gammaglutamyltransferase on incidence of diabetes mellitus: A longitudinal study [J]. Medicine, 2020, 99(11): e18963.
[3] ZOU Yang, ZHONG Ling, HU Chong, et al. Association between the alanine aminotransferase/ aspartate aminotransferase ratio and new-onset nonalcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study[J]. Lipids in Health and Disease, 2020, 19(1): 245.
[4] 薛丽, 黄芳, 张彦平, 等. 丙肝患者血清HCV-RNA 含量与肝功能及血常规指标的相关性[J]. 现代检验 医学杂志, 2017, 32(5):110-114. XUE Li, HUANG Fang, ZHANG Yanping, et al. Relevance of serum HCV-RNA level with routine liver function indices and blood routine parameters in patients with hepatitis C[J].Journal of Modern Laboratory Medicine, 2017, 32(5):110-114.
[5] SIRCAR K, HEWLETT B R, HUIZINGA J D, et al. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors[J]. The American Journal of Surgical Pathology, 1999, 23(4): 377-389.
[6] JOENSUU H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor[J]. Human Pathology, 2008, 39(10): 1411-1419.
[7] 朱文芳, 沈建军, 付涛, 等.血清GPDA 联合肿瘤 标志物对胃癌早期诊断的临床价值[J]. 现代检验医 学杂志, 2017,32(4):110-112. ZHU Wenfang, SHEN Jianjun, FU Tao, et al. Clinical value of serum GPDA associated tumor markers for early diagnosis of gastric cancer [J]. Journal of Modern Laboratory Medicine, 2017,32(4):110-112.
[8] 乔新民, 王丽君.血清CYFRA21-1,CA125,CA19-9 水平联合检测在胃癌诊断中的价值[J].现代检验医 学杂志, 2020, 35(1):90-93. QIAO Xinmin, WANG Lijun. Value of combined detection of serum CYFRA21-1, CA125 and CA19-9 levels in the diagnosis of gastric cancer [J]. Journal of Modern Laboratory Medicine, 2020, 35(1):90-93.
[9] 卓传尚, 柳丽娟, 周淑燕.AFP-L3 和PIVKA- Ⅱ检 测对高危人群良恶性肝病的鉴别诊断价值[J]. 现代 检验医学杂志, 2017, 32(4):40-42, 46. ZHUO Chuanshang, LIU Lijuan, ZHOU Shuyan. Performance of serum AFP-L3 and PIVKA- Ⅱ in differential diagnosis of benign and malignant liver disease in high risk population [J]. Journal of Modern Laboratory Medicine, 2017, 32 (4): 40-42,46.
[10] 王军, 张文胜, 裴效瑞, 等. 胃肠道间质瘤临床诊 断与治疗研究进展[J]. 中国肿瘤临床与康复, 2019, 26(1):122-124. WANG Jun, ZHANG Wensheng, PEI Xiaorui, et al. Progress in clinical diagnosis and treatment of gastrointestinal stromal tumor [J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2019, 26(1):122- 124.
[11] SCHEIPNER L, SMOLLE M A, BARTH D, et al. The AST/ALT ratio is an independent prognostic marker for disease-free survival in stage II and III colorectal carcinoma[J]. Anticancer Research, 2021, 41(1): 429-436.
[12] LIU Xu, MENG Jing, XU Hongqin, et al. Alphafetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma[J]. Medicine (Baltimore), 2019 ,98(17):e15414.
[13] DURHAN A, SENLIKCI A, KOSMAZ K, et al. An evaluation of the effect of preoperative inflammationbased factors on survival in gastric cancer patients[J]. Journal of the College of Physicians and Surgeons- Pakistan, 2021, 31(3): 282-287.
[14] 赵杰, 余海波, 朱运海, 等.肝癌根治术前GGT, ALT/AST 和术后临床病理特征与预后的关系[J]. 中 华普通外科杂志, 2019, 34(4):328-331. ZHAO Jie, YU Haibo, ZHU Yunhai, et al. Preoperative GGT, ALT/AST relates to clinicopathological features and prognosis after radical surgery for hepatocellular carcinoma [J]. Chinese Journal of General Surgery, 2019, 34(4):328-331.
[15] 王姗.血清GGT 和AST/ALT 对原发性肝癌预后的 评估价值[J].临床肝胆病杂志, 2019, 35(10):2334. WANG Shan. Prognostic value of serum GGT and AST / ALT in patients with primary liver cancer [J]. Journal of Clinical Hepatology, 2019, 35(10):2334.
[16] RIEDL J M, POSCH F, PRAGER G, et al. The AST/ ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study[J]. Ther Adv Med Oncol, 2020,12:1758835919900872.
[17] ZHOU Jiatong, HE Zhaowei, MA Shenfei, et al. AST/ ALT ratio as a significant predictor of the incidence risk of prostate cancer[J]. Cancer Medicine, 2020, 9(15): 5672-5677.
[18] GORGEL S N, KOSE O, KOC E M, et al. The prognostic significance of preoperatively assessed AST/ ALT (De Ritis) ratio on survival in patients underwent radical cystectomy[J]. International Urology and Nephrology, 2017, 49(9): 1577-1583.
[19] HUANG Hao, WANG Xueping, LI Xiaohui, et al. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/ AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma[J]. BMC Cancer, 2017, 17(1): 544.
[20] 吴佳, 李钟声, 姚寒晖.胃癌患者术前血清丙氨酸氨 基转移酶及天冬氨酸氨基转移酶比值与其预后的关 联[J]. 中华全科医学, 2020, 18(11):1854-1856,1932. WU Jia, LI Zhongsheng, YAO Hanhui. Association of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio and prognosis in patients with gastric cancer [J]. Chinese Journal of General Practice, 2020, 18(11):1854-1856,1932.
[21] 韩帮岭, 汪亦民, 薛英威.术前血清丙氨酸氨基转 移酶与天冬氨酸氨基转移酶比值对胃癌患者预后的 影响[J].中华胃肠外科杂志, 2020,23(1):65-70. HAN Bangling, WANG Yimin, XUE Yingwei. Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer [J]. Chinese Journal of Gastrointestinal Surgery, 2020,23(1):65-70.
[22] GAITANIDIS A, EL LAKIS M, ALEVIZAKOS M, et al. Predictors of lymph node metastasis in patients with gastrointestinal stromal tumors (GISTs)[J]. Langenbeck’s Archives of Surgery, 2018, 403(5): 599- 606.
[23] 郑瑞, 庞涛, 张新, 等.139 例胃肠道间质瘤患者临 床疗效及预后分析[J]. 中华保健医学杂志, 2019, 21(4):338-340. ZHENG Rui, PANG Tao, ZHANG Xin, et al. Clinical efficacy and prognosis of 139 patients with gastric stromal tumor [J]. Chinese Journal of Health Care and Medicine, 2019, 21(4):338-340.

相似文献/References:

[1]穆润清,田 文.辽宁地区成年体检人群ALT,AST季节性变异的研究[J].现代检验医学杂志,2016,31(02):32.[doi:10.3969/j.issn.1671-7414.2016.02.010]
 MU Run-qing,TIAN Wen.Study on the Seasonal Variation of Aminotransferase for Population of Liaoning[J].Journal of Modern Laboratory Medicine,2016,31(02):32.[doi:10.3969/j.issn.1671-7414.2016.02.010]
[2]郭 燕,贺 晨,段 勇,等.无偿献血者ALT 水平异常与HBI,OBI,HCI 和OCI 的相关性研究[J].现代检验医学杂志,2020,35(02):18.[doi:10.3969/j.issn.1671-7414.2020.02.006]
 GUO Yan,HE Chen,DUAN Yong,et al.Investigating the Correlation of Abnormal ALT Level andHBI, OBI, HCI, OCI in Volunteer Blood Donors[J].Journal of Modern Laboratory Medicine,2020,35(02):18.[doi:10.3969/j.issn.1671-7414.2020.02.006]
[3]刘振国a,王婷b,卢晓娥a.CVVHDF联合HP治疗蜂蜇伤患者临床生化指标的变化研究[J].现代检验医学杂志,2015,30(05):115.[doi:10.3969/j.issn.1671-7414.2015.05.035]
 LIU Zhen-guoa,WANG Tingb,LU Xiao-ea.Analysis of the Changes of Clinical and Biochemical Indexes in Treatment of Continuous Venovenous Hemodiafiltration Combined with Hemoperfusion in Patients with Bee Stings[J].Journal of Modern Laboratory Medicine,2015,30(02):115.[doi:10.3969/j.issn.1671-7414.2015.05.035]

备注/Memo

备注/Memo:
作者简介:向文采(1986-),男,本科,主治医师。研究方向:胃肠道及肛管疾病、急腹症、腹壁疝等疾病的治疗及研究。
通讯作者:刘俊,E-mail:liujun198502@sina.com。
更新日期/Last Update: 1900-01-01